Quick Answer
Elevance Health, Inc. reported Diluted EPS of $25.21 per share for fiscal year 2025.
Elevance Health, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $25.21 | -1.8% |
| 2024 | $25.68 | +1.8% |
| 2023 | $25.22 | +3.9% |
| 2022 | $24.28 | -2.7% |
| 2021 | $24.95 | +38.8% |
| 2020 | $17.98 | -2.7% |
| 2019 | $18.47 | +30.2% |
| 2018 | $14.19 | -1.1% |
| 2017 | $14.35 | +55.8% |
| 2016 | $9.21 | -1.8% |
| 2015 | $9.38 | +4.3% |
| 2014 | $8.99 | +9.6% |
| 2013 | $8.20 | +0.2% |
| 2012 | $8.18 | +12.8% |
| 2011 | $7.25 | +4.5% |
| 2010 | $6.94 | -29.8% |
| 2009 | $9.88 | +107.6% |
| 2008 | $4.76 | -14.4% |
| 2007 | $5.56 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.32 | +22.0% | -31.1% |
| June 30, 2025 | $7.72 | -21.6% | -19.7% |
| March 31, 2025 | $9.61 | +0.2% | +120.4% |
| September 30, 2024 | $4.36 | -20.0% | -55.7% |
| June 30, 2024 | $9.85 | +26.4% | +2.7% |
| March 31, 2024 | $9.59 | +15.5% | +76.0% |
| September 30, 2023 | $5.45 | -17.7% | -30.0% |
| June 30, 2023 | $7.79 | +15.8% | -6.1% |
- Elevance Health, Inc. showed a decrease of -1.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2007–2025 period, Elevance Health, Inc.’s diluted eps has grown by 353.4% (from $5.56 per share to $25.21 per share).
- The most recent figure is from Elevance Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: